
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1020 | 1060 | 1171 | 1169 | 1283 | 1411 |
Fund Return | 1.98% | 6.02% | 17.08% | 5.34% | 5.11% | 3.5% |
Place in category | 2214 | 582 | 321 | 521 | 603 | 404 |
% in Category | 61 | 18 | 11 | 20 | 30 | 39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Adamant Medtech T EUR | 1.5B | 7.53 | 6.36 | 10.55 | ||
Bellevues Lux BB Adamant Medtech HB | 1.5B | 7.58 | 1.20 | 7.49 | ||
Adamant Medtech B EUR | 1.5B | 7.46 | 5.94 | 10.11 | ||
Adamant Medtech I EUR | 1.5B | 7.58 | 6.68 | 10.90 | ||
LU1477743386 | 336.93M | 2.01 | 0.11 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Flossbach von Storch S Multiple Opf | 25.01B | 4.93 | 6.14 | 6.03 | ||
Flossbach von Storch S Multiple Opi | 25.01B | 4.47 | 5.77 | 5.61 | ||
Flossbach von Storch S Multiple Ope | 25.01B | 4.35 | 5.07 | 4.95 | ||
LU1663838545 | 14.54B | 2.51 | 4.04 | - | ||
Flossbach von Storch Multiple Oppoi | 11.19B | 4.38 | 5.23 | 5.35 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SPDR S&P 500 UCITS | IE00B6YX5C33 | 15.01 | 439.95 | +0.68% | |
Xtrackers MSCI USA UCITS ETF 1C | IE00BJ0KDR00 | 8.19 | 153.16 | +0.92% | |
Xtrackers MSCI Emerging Markets UCITS | IE00BTJRMP35 | 5.63 | 55.432 | -0.35% | |
Btp Tf 1,50% Gn25 Eur | IT0005090318 | 3.39 | 99.82 | -0.04% | |
Xtrackers MSCI Japan UCITS 1C | LU0274209740 | 3.36 | 6,560.0 | +0.63% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review